Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Lymphocytic Leukemia (ALL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00149136
What this trial is testing

Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly With Imatinib Mesylate (STI571) and Chemotherapy.

Who this might be right for
Acute Lymphocytic Leukemia
Hospices Civils de Lyon 30
Large-scale testing (Phase 3)Study completedNCT00300664
What this trial is testing

Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients.

Who this might be right for
Multiple MyelomaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+1 more
Royal Marsden NHS Foundation Trust 150
Early research (Phase 1)Study completedNCT00049699
What this trial is testing

VNP40101M in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Vion Pharmaceuticals
Testing effectiveness (Phase 2)UnknownNCT05598593
What this trial is testing

Modified TBF Regimen as Conditioning Regimen Prior to Allo-HSCT for T-ALL/LBL

Who this might be right for
Cytarabine+Thiotepa + Fludarabine + BusulfanT Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
First Affiliated Hospital of Zhejiang University 70
Not applicableLooking for participantsNCT05811845
What this trial is testing

Mercaptopurine Therapeutic Drug Monitoring to Optimize the Maintenance Phase of Childhood ALL

Who this might be right for
Acute Lymphoblastic Leukemia
IRCCS Burlo Garofolo 250
Early research (Phase 1)Study completedNCT00031941
What this trial is testing

CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Institutes of Health Clinical Center (CC)
Not applicableUnknownNCT03260101
What this trial is testing

Non-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 Study

Who this might be right for
Acute Myelogenous Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)Non Hodgkin Lymphoma (NHL)+1 more
Cellect Biotechnology 12
Not applicableEnded earlyNCT01761682
What this trial is testing

Acute Lymphoblastic Leukemia Registry at Asan Medical Center

Who this might be right for
Leukemia, Acute LymphoblasticPrecursor B-Cell Lymphoblastic LeukemiaLeukemia, Biphenotypic, Acute+2 more
Asan Medical Center 200
Early research (Phase 1)Study completedNCT00416923
What this trial is testing

Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphoma
University of California, San Francisco 10
Testing effectiveness (Phase 2)Study completedNCT00041327
What this trial is testing

Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma

Who this might be right for
Lymphoma
AIDS Malignancy Consortium 19
Early research (Phase 1)Ended earlyNCT00464113
What this trial is testing

Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia

Who this might be right for
Chronic Myeloid LeukemiaLeukemia, Lymphoblastic, Acute, Philadelphia-Positive
Exelixis 49
Not applicableStudy completedNCT02300961
What this trial is testing

Feasibility Neurocognitive Outcome After Transplant

Who this might be right for
Stem Cell TransplantationPediatric CancerAcute Lymphoblastic Leukemia
Stanford University 17
Testing effectiveness (Phase 2)Study completedNCT00096161
What this trial is testing

Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic Leukemia+7 more
Fred Hutchinson Cancer Center 36
Testing effectiveness (Phase 2)Study completedNCT00601718
What this trial is testing

Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+34 more
University of Washington 29
Testing effectiveness (Phase 2)UnknownNCT00363090
What this trial is testing

Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Toronto Sunnybrook Regional Cancer Centre 84
Large-scale testing (Phase 3)Ended earlyNCT00038805
What this trial is testing

Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT03249870
What this trial is testing

Study of Inotuzumab Ozogamicin Combined to Chemotherapy in Older Patients With Philadelphia Chromosome-negative CD22+ B-cell Precursor ALL

Who this might be right for
Acute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome (Ph)-Negative CD22+ B-cell Precursor (BCP)
Versailles Hospital 131
Testing effectiveness (Phase 2)WithdrawnNCT00837174
What this trial is testing

Relapsed and/or Refractory Non-Hodgkin Lymphoma Study

Who this might be right for
Non-Hodgkin Lymphoma
The Methodist Hospital Research Institute
Testing effectiveness (Phase 2)Looking for participantsNCT06064903
What this trial is testing

CD7-CAR-T Cells in Pediatric Relapsed/Refractory CD7+ T-ALL/LL

Who this might be right for
T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
Bambino Gesù Hospital and Research Institute 26
Not applicableWithdrawnNCT05968170
What this trial is testing

TCRαβ/CD19 Depletion of Stem Cell Grafts for Transplant

Who this might be right for
Graft Vs Host DiseaseGraft-versus-host-diseaseAcute Myeloid Leukemia+3 more
Neena Kapoor, M.D.
Next Page